Which drug wins for lupus kidney disease? new study pits telitacicept against belimumab
NCT ID NCT07031674
First seen Feb 02, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study looked back at medical records of 56 adults with lupus nephritis to compare two drugs: telitacicept and belimumab. The goal was to see which one better protects kidney function and causes fewer side effects. Participants had already been on one of the drugs for at least 12 weeks. The study did not give any new treatments—it just analyzed existing data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qianfoshan Hospital
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.